PRNewsWire
23 Jun 2026, 10:50 UTC · 12w ago
Verdict
Headline takes no side. We score BDX +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 86% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
BD's CentroVena One™ Insertion System was awarded an Innovative Technology contract from Vizient, the largest provider-driven healthcare performance improvement company in the U.S.
More positive than 76% of claims this week
The CentroVena One™ system is an all-in-one design that reduces central line insertion steps by 30% and maximum procedure time by 50% compared to standard techniques.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 53% of claims this week
Which stocks this story touches
More positive than 86% of ticker scores this week
The company's CentroVena One system was awarded an Innovative Technology contract by Vizient, validating its innovation and expanding market access.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2d ago
+28.6%
Price agrees with the score
$180.94 vs $140.71 close before publication (Jun 22) · not market-adjusted
BDX chart →
